Detalhe da pesquisa
1.
Early recapture of response with tofacitinib 10 mg twice daily in patients with ulcerative colitis in OCTAVE Open following dose reduction or treatment interruption in OCTAVE Sustain.
J Gastroenterol Hepatol
; 39(2): 264-271, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37953548
2.
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis.
Dig Dis Sci
; 68(6): 2624-2634, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36739367
3.
Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 20(8): 1821-1830.e3, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33127596
4.
Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status.
Clin Gastroenterol Hepatol
; 20(3): 591-601.e8, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33684552
5.
Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 20(1): 116-125.e5, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33039585
6.
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials.
Dig Dis Sci
; 66(8): 2732-2743, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32816215
7.
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
N Engl J Med
; 376(18): 1723-1736, 2017 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28467869
8.
Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 18(1): 123-132.e3, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31077827
9.
Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials.
Clin Gastroenterol Hepatol
; 17(8): 1541-1550, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30476584
10.
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 17(1): 139-147, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30012431
11.
Exposure-response characterization of tofacitinib efficacy in moderate to severe ulcerative colitis: Results from a dose-ranging phase 2 trial.
Br J Clin Pharmacol
; 84(6): 1136-1145, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29377257
12.
Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial.
Gastroenterology
; 150(1): 96-102, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26376350
13.
Ulcerative Colitis Treatment Patterns and Cost of Care.
Value Health
; 20(6): 752-761, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28577692
14.
Correction to: Characterization of Creatine Kinase Levels in TofacitinibTreated Patients with Ulcerative Colitis: Results from Clinical Trials.
Dig Dis Sci
; 66(9): 3214-3215, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33037970
15.
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
N Engl J Med
; 377(5): 496-7, 2017 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28767341
16.
Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis.
N Engl J Med
; 367(7): 616-24, 2012 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22894574
17.
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes.
BMC Gastroenterol
; 15: 14, 2015 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25651782
18.
Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program.
Patient
; 16(2): 95-103, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36336750
19.
Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program.
Therap Adv Gastroenterol
; 16: 17562848231189122, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37560161
20.
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs.
Rheumatol Ther
; 10(2): 357-373, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36526796